This inventor holds 2 USPTO granted patents. Top assignee: Dupont Pharmaceuticals Company. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Thomas Peter Maduskuie, Jr: Innovator in Factor Xa Inhibition
Introduction
Thomas Peter Maduskuie, Jr. is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for factor Xa. With a total of 2 patents, his work has implications for anticoagulant therapies.
Latest Patents
Maduskuie’s latest patents include innovative compounds that serve as inhibitors of factor Xa. The first patent describes .alpha.-branched anilines, toluenes, and analogs thereof, specifically m-amidino phenyl analogs that are useful in this capacity. The second patent focuses on N-(amidinophenyl) cyclourea analogs, which also function as inhibitors of factor Xa. These inventions highlight his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Currently, Maduskuie is associated with DuPont Pharmaceuticals Company, where he continues to work on groundbreaking research. His expertise in pharmaceutical chemistry has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Throughout his career, Maduskuie has collaborated with talented individuals such as Mimi Lifen Quan and Petrus Fredericus Stouten. These partnerships have fostered an environment of innovation and creativity, leading to significant advancements in their field.
Conclusion
Thomas Peter Maduskuie, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to factor Xa inhibition are paving the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile